JUL 16
New Users Please Click to Register
Renew or Upgrade your Existing  Account

Hypertension, Dialysis and Clinical Nephrology
VBOOTHS :  Google :  PubMed  :   Scholar  :   K/DOQI :  UpToDate :  eGFR
Slides/audio/handouts:    RRI-2015  :  Brigham-2014  :  RRI-2014  :  Brigham-2013  :  ISHD Shanghai-2013  :  ASH-2013  :  ADC-2013 (audio)  :  ASDIN-2013  :  RRI-2013  :  ISHD-HDU-Chicago-2012/14  :  Brigham-2012  :  ASH-2012  :  ADC-2012 (audio)  :  NANT-2012  :  ASDIN-2012  :  RPA-2012  :  RRI-2012  :  Brigham-2011  :  ASH-2011  :  ADC-2011  :  NANT-2011  :  ASDIN-2011  :  RPA-2011  :  RRI-2011  :  Fistula First-2010  :  ADC-2010  :  NANT-2010  :  ASDIN-2010  :  RRI-2010  :  RPA-2010  :  Network9,10-2008  : 
TalksbyDate   Search HDCN:  FreeTalks   (key):   Articles :  Abstracts :  Audiofiles :  SlideTalks :  LegacyTalks  
free ISHD Hemodialysis University Chicago (2012-2014)
free ISHD Hemodialysis University Shanghai 2013
free ISHD Hemodialysis University Chicago (2014)
free ISHD Hemodialysis University India (2014)


Harvard Brigham Nephrology Board Review Course (Part 2)   
Flash or IPAD slide/audio
Boston, MA; August 2014

Sodium Disorders
David B. Mount, MD





Advances in CKD 2015 (PART 4)   
Flash or IPAD slide/audio
New Orleans, LA; January 2015


Vascular glycocalyx sodium store - Determinant of salt sensitivity
Hans Oberleithner, MD

Debate: Salt-reconciling public policy and specific indications; why are they not identical?
- No
Paul K. Whelton, MD
- Yes
Morton Satin, PhD


Hypertension, Cardiovascular
Masked hypertension in African Americans
Screening for hyperglycemia
Long-term beta-blocker therapy after CABG
Renal hyperfiltration as a risk marker
BP meds and BP targets in nursing home patients
RCT for early delivery at 34-37 weeks with HTN
Early thrombectomy in ischemic stroke
Stent-retriever thrombectomy after t-PA in stroke
Heightened sympathetic activity and HTN treatment failure
Aortic blood flow reversal with stiff aorta and GFR
Anti-HTN meds and risk of falls in the elderly

CKD, Dialysis
Cardiac troponin cutoffs in CKD
Short stature good in patients with CKD
Cinacalcet vs. vitamin D analogs on FGF23
Cinacalcet vs. vitamin D analogs as monotherapy RCT
Thyroid function in normal range and CAD risk - meta
ISN zero by 2025 initiative for AKI
Permissive underfeeding in critically ill adults RCT
Rivaroxaban in HD patients: dose finding study
Dietary intake in ESRD is well below recs: are the recs wrong?

Clinical Nephrology
Hyponatremia with desmopressin for nocturnal polyuria
Copeptin levels linked to number of renal cysts

This update's selected ASN 2014 abstracts

(last batch)

Skin autofluorescence and risk.

Errors in self-cannnulation and access complications in home HD; QC to preserve veins in CKD; Doppler to guide AV cannulation; Role of access procedure station; Vascular access life table analysis.

Changes in RKF with 2/week vs. 3/week HD; Blood pH changes and indoxyl sulfate dialytic removal; High-flux dialysis and outcomes with and without RKF; Beta-2-M population kinetics; Protein-bound uremic toxin reduction by gut charcoal; Better clearance of protein-bound toxins and serum levels; Skin autofluorescence and tissue glycation product levels; Trends for treatment time for in-center HD; Associations with missed HD treatments in DOPPS.

Dialysate sodium errors; BIA volumes and postdialysis hypotension; Interdialytic interval and cognitive function; Factors associated with IDH; IDWG trends over time; Reduction in DNa good; Hydration status and mortality in European FMC dataset; Patient-valued dialysis treatment benefits; Short daily HD for nursing homes; Daily HD and vascular stiffness; Progression of atherosclerosis with nocturnal HD.

Biocompatible vs. conventional PD fluids; Culture negative peritonitis and PD fluid culture methods; Encapsulating PD sclerosis in Saudi Arabia; Surprise question vs. prediction model for HD outcome; Venous catheter and survival in large program; BMI vs. short-term vs. long-term outcome in PD; Dietary fiber lowers plasma AGEs and betters outcome; Antibiotic stability in PD fluid with icodextrin; Major bleeding incidents in HD; Protein intake and phosphorus control in PD; Time-averaged serum Ca and outcome; High dialysate Ca, PTH, and outcomes; non-oxidized PTH and CV events; Cinacalcet use and calciphylaxis; Sevelamer use lowers uric acid; Glycated albumin vs. HbA1C in the 4D trial; Pegylated interferon alpha 2A and ribavirin for HCV in ESRD.

Clinical Nephrology
ZS-9 as emergency treatment of hyperkalemia.  (Kidney Week 2014...)

News     Hit reload / refresh
RSS  Click on RSS for details of each news story.
Updated: September 04, 2015 (Sep04)
Sep04 Hedge fund quant proposes a disease-specific false-positive rate to FDA for drug approval.
Aug31 Spanish style mid-day "siestas" linked to lower blood pressure and better heart structure.
Aug31 Fimrenone, a selective MRA antagonist from Bayer shows promising heart failure effects.
Aug30 High blood flow rate and high negative venous pressure lead to microbubbles
Aug27 FDA approves 2nd PCSK9 inhibitor, Repatha, to lower LDL cholesterol
Aug22 Packaging medications together by date to be taken and time of day.
Aug19 Low levels of lactobacillus in the vagina associated with premature births
Aug18 Doctors will be able to look at your beating heart or at your colon in 3-D virtual reality.
Aug17 Recombinant elastase (vonapanitase) for AV fistula patency prolongation
Aug15 Hemodialysis University at Chicago, October 1-3, 2015
Aug14 Google partnering with Dexcom in continuous glucose monitoring device.
Aug13 Transplant anti-rejection drugs and risk of melanoma
Aug03 New artificial blood vessel coating makes them resistant to thrombosis.
Jul31 Paid kidney donation and the Iranian model in the New York Times
Jul16 Using salt microspheres to reduce sodium intake
Jul08 Valsartan combined with sacubitril (neprilysin inhibitor) improves heart failure patient survival.
Jul08 153 lab tests for under $10 from a finger prick test done at a local drugstore.
Jun29 Drink when thirsty advice for athletes from Sports Medicine group
May30 Vagal nerve stimulation lowers inflammatory response in rheumatoid arthritis
May27 Binding site for PLA2R antibodies identified and blocking molecules synthesized
General Advances Emphasis
Preserving residual renal function in dialysis: what we know
Drs. Patel and Hu review what we can do at the present state of incomplete knowledge; in the May/Jun issue of Seminars in Dialysis. (more...)

Unnecessary renal replacement therapy for acute kidney injury is harmful for renal recovery
Drs. Clark and Bagshaw discuss the potential harms of dialysing patients with suspected AKI too early; in the Jan/Feb issue of Seminars in Dialysis. (more...)

Dietary protein and fiber in end stage renal disease
Tammy Sirich talks about dietary protein, fiber, gut transit time, and gut microbes in uremia, and new ways to modulate blood levels of indoxyl sulfate and p-cresyl sulfate; in the Jan/Feb issue of Seminars in Dialysis. (more...)

Thyroid function tests in end stage renal disease.
Drs. Kulkarni and Holley describe the emerging evidence that thyroid dysfunction should be sought and perhaps treated in dialysis patients; in the Nov/Dec issue of Seminars in Dialysis, which has articles about the usefulness of many other laboratory tests in ESKD as well.. (more...)

Hypomagnesemia, chronic kidney disease and cardiovascular mortality: Pronounced association but unproven causation
Dr. Dousdampanis and colleagues review the latest evidence regarding low magnesium and CKD, and whether we should treat it; in the October issue of Hemodial Int (more...)

Sailing between Scylla and Charybdis: The high serum K - low dialysate K quandary
Should we use a 3 K bath for most patients? Are 1K and zero K bath's a no-no? Drs. Labriola and Jadoul review the evidence in the Sept/Oct issue of Seminars in Dialysis. (more...)

A stepwise approach for the management of poisoning with extracorporeal treatments Few are using hemoperfusion anymore, and poisoning requires an integrated approach. Dr. Ghannoum and colleagues provide a nice overview in the July/Aug issue of Seminars in Dialysis. (more...)

Hemodialysis for infants, children, and adolescents
Drs. Kaur and Davenport review techniques for performing hemodialysis in children; in the July issue issue of Hemodial Int (more...)

Urgent-start peritoneal dialysis: what are the problems and their solutions? Dr. Mahnensmith discusses this new approach to AKI or acute-on-chronic kidney failure, its advantages and potential problems; in the May/June issue of Seminars in Dialysis. (more...)

Intradialytic hypotension: Frequency, sources of variation and correlation with clinical outcome
Dr. Sands and colleagues delve into large databases to better understand the occurrence and risk factors for intradialytic hypotension; in the April issue of Hemodial Int (more...)

Hemodialysis-associated cardiomyopathy: a newly defined disease entity Drs. McIntyre and Odudu describe their latest results regarding myocardial stunning; in the Mar/Apr issue of Seminars in Dialysis. (more...)

Nonadherence in dialysis patients: prevalence, measurement, outcome, and psychological determinants Dr. Clarke and colleagues review why adherence is so important to outcomes, and methods that have been suggested to improve this problem; in the Jan/Feb issue of Seminars in Dialysis. (more...)

Approach to prophylactic measures for central venous catheter- related infections in hemodialysis: A critical review
Dr. Silva and colleagues go over what we know works, and which treatments are still experimental; in the Jan-Feb issue of Hemodial Int (more...)

Infrequent dialysis: a new paradigm for hemodialysis initiation Dr. Rhee and colleagues present a novel idea; starting out with twice-a-week dialysis in incident patients with substantial residual kidney function, and discuss potential benefits vs. risks. in the Nov/Dec issue of Seminars in Dialysis. (more...)

  SUMMARIES of Recent Slide/Audio Symposia in reverse chronological order

  Advances in CKD (Renal Research Institute) (2015) (2014) (2013) (2012) (2011) (2010) (2009)
  Kidney Disease in Type 2 Diabetes: Disease Progression and Emerging Therapies
Philip Raskin, MD; Jennifer Marks, MD, Jerry Yee, MD, Mark Molitch, MD. (2011)
  The Brigham Renal Board Review Course: Selected Lectures (2014) -- (2013) -- (2012) -- (2011)
  American Society of Hypertension (2013)   (2012)   (2011)
  Renal Physicians Association (2012) (2011) (2010) (2009)
  American Society for Diagnostic and Interventional Nephrology (ASDIN) (2013) (2012) (2011) (2010) (2009)
  Fistula First (2010)
  Annual Dialysis Conference (audiofiles) (2012)   (2011) (2010) (2009)
  National Association of Nephrology Technologists (NANT) (2012) (2011) (2010) (2009)
  American Society for Nephrology Renal Week (2009) (2008) (2007)
  American Society for Nephrology Board Review Course (2008) (2007)
  American Society for Nephrology Renal Week (audiofiles) (2009) (2008) (2007)
  Preparing for the New Medical Director Responsibilities (Network 9/10 - RPA Special Symposium)



Site Description:
Hypertension, Dialysis, and Clinical Nephrology provides up-to-date, selected information on renal disorders and their treatment (hemodialysis, peritoneal dialysis), and about hypertension, dialysis, and clinical nephrology topics.
Hypertension, Dialysis, and Clinical Nephrology is a place for physicians and nurses who treat patients with kidney or renal disease. Here physicians and nurses can find answers to frequently asked hypertension, dialysis, and nephrology questions (FAQ), pointers to recent review articles, and summaries of hot new hypertension, dialysis, and nephrology papers, abstracts, and meeting presentations. Also, information about medical products, devices, services, and drugs pertaining to hypertension, dialysis, and clinical nephrology are provided, as is a list of links to relevant hypertension / dialysis / transplantation organizations, medical provider networks, and databases. Much of the information presented is collected from a distinguished editorial board composed of specialists in the field of kidney or renal disease.

The information at this server is provided with the understanding that the publisher, authors, and advisors are not rendering medical or medical professional services. Medicine is a rapidly changing area, and efforts have been made to provide information that is medically correct at the time of publication. However, there may be mistakes, both typographical and in content. The material provided should be used only as a general guide and not the ultimate source of information. The material should not be used to form the basis of personal or professional decisions. The authors, advisors, and publisher shall have neither liability not responsibility to any person or entity with respect to any loss or damage alleged to be caused directly or indirectly by the information presented on this server.

Copyright statement:
Disclaimer: The reader is responsible for discerning the validity, factuality or implications of information posted here. The content of posts on this site, including but not limited to links to other web sites, are the expressed opinion of the original poster and are in no way representative of or endorsed by the owners or administration of this website. The posts on this website are the opinion of the specific author and are not statements of advice, opinion, or factual information on behalf of the owner or administration of HDCN or Medtext, Inc. This site is provided "as is" without warranty of any kind, either expressed or implied. You should not assume that this site is error-free or that it will be suitable for the particular purpose which you have in mind when using it. In no event shall hdcn.com or Medtext, Inc. be liable for any special, incidental, indirect or consequential damages of any kind, or any damages whatsoever, including, without limitation, those resulting from loss of use, data or profits, whether or not advised of the possibility of damage, and on any theory of liability, arising out of or in connection with the use or performance of this site or other documents which are referenced by or linked to this site. Fair Use Notice: This site may contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. Users may make such material available in an effort to advance awareness and understanding of issues relating to civil rights, economics, individual rights, international affairs, liberty, science & technology, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C.Section 107, the material on this site is distributed to those who have expressed a prior interest in receiving the included information for research and educational purposes. In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article. Please remember YOU are responsible for what YOU post on the internet and YOU could be sued by the original copyright holder if you do not honor these rules. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of "Fair Use" and legitimately infringes on yours or your clients copyright we may be contacted concerning copyright matters at: Medtext, Inc. 15W560 89th Street Willowbrook, IL 60527 tel: 630-325-3276 email: editor -at sign- hdcn.com If you require a courier address please send a fax or email and we will provide you with the required information. In accordance with section 512 of the U.S. Copyright Act our contact information has been registered with the United States Copyright Office. "Safe Harbor" noticing procedures as outlined in the DMCA apply to this website concerning all 3rd party posts published herein. If notice is given of an alleged copyright violation we will act expeditiously to remove or disable access to the material(s) in question. It is our strict policy to disable access to accounts of repeat copyright violation offenders. We will also ban the IP address of repeat copyright violators from future posting on this website with or without a registered account. All 3rd party material posted on this website is copyright the respective owners / authors. hdcn.com makes no claim of copyright on such material. For more information please visit: http://www.law.cornell.edu/uscode/17/107.shtml

Published by Medtext, Inc., Willowbrook, IL, 630-325-3276
E-mail to: editor (at sign) hdcn.com

96 97 98 99